S
ALNA

SignatureFD’s Allena Pharmaceuticals ALNA Stock Holding History

SignatureFD’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-200
Closed – – 2867
2020
Q4 		$0 Hold
200
– – ﹤0.01% 2763
2020
Q3 		$0 Hold
200
– – ﹤0.01% 2815
2020
Q2 		$0 Sell
200
-1,300
-87% -$2.18K ﹤0.01% 2723
2020
Q1 		$1K Buy
+1,500
New +$3K ﹤0.01% 2249

Other funds holding ALNA

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

SignatureFD's ALNA Position: Q1 2021 in Review

SignatureFD sold out of Allena Pharmaceuticals (ALNA) in Q1 2021, closing a stake of 200 shares.

SignatureFD first reported a position in ALNA in Q1 2020 and held it in 4 quarters. The position peaked at $1K in Q1 2020. 30 funds tracked by Wall St. Rank hold ALNA as of Q1 2021.

  • SignatureFD reported no remaining Allena Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • SignatureFD sold 200 Allena Pharmaceuticals shares in Q1 2021.
  • SignatureFD first reported a position in Allena Pharmaceuticals in Q1 2020 and held it in 4 quarters.
  • SignatureFD's Allena Pharmaceuticals position peaked at $1K in Q1 2020.
  • 30 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q1 2021.

Based on SignatureFD's 13F filing for Q1 2021, filed 30 Apr 2021.